Two subjects with Parkinson's disease who had long-term survival of transplanted fetal
mesencephalic dopaminergic neurons (11–16 years) developed α-synuclein–positive Lewy …

Synaptic dopamine release from embryonic nigral transplants has been monitored in the
striatum of a patient with Parkinson's disease using [11 C]-raclopride positron emission …

Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative
movement disorder that is characterised by autonomic failure, cerebellar ataxia, and …

Severe dyskinesias during the 'off' phases (periods of increased Parkinson's disease (PD)
disability) have been observed following intrastriatal transplantation of human embryonic …

Objective To assess the ability of 5 cerebrospinal fluid (CSF) biomarkers to differentiate
between common dementia and parkinsonian disorders. Design A cross-sectional, clinic-based …

Thalamic deep brain stimulation (DBS) is proven to suppress tremor in Parkinson’s disease (PD)
and essential tremor (ET). However, there are few reports on its long-term efficacy. We …

Importance Recent advances in stem cell technologies have rekindled an interest in the use
of cell replacement strategies for patients with Parkinson disease. This study reports the …

Five parkinsonian patients were transplanted bilaterally into the putamen and caudate nucleus
with human embryonic mesencephalic tissue from between seven and nine donors. To …

Clinical trials using cells derived from embryonic ventral mesencephalon have shown that
transplanted dopaminergic neurons can survive and function in the long term, as …

Multiple system atrophy (MSA) is a Parkinson's Disease (PD)‐like α‐synucleinopathy clinically
characterized by dysautonomia, parkinsonism, cerebellar ataxia, and pyramidal signs in …